期刊文献+

白细胞介素28B基因多态性与丙型肝炎患者干扰素疗效的关系 被引量:2

Association of interleukin-28B polymorphisms with the response to interferon treatment of chronic hepalitis C
原文传递
导出
摘要 影响慢性丙型肝炎患者IFN抗病毒疗效的因素有宿主因素、病毒因素以及其他作用于病毒和宿主的外在因素,如吸烟、环境污染、合并其他病毒感染等。而最近的研究表明宿主IL-28B基因多态性与IFN抗HCV疗效的关系尤为重要。此文对IL-28B基因多态性对IFN抗HCV疗效影响进行综述。 It has been documented that host factors, viral factors and other external factors acting on host and virus such as smoking, environmental pollution and co-infection with other viruses, affect the outcomes of chronic hepatitis C patients treated with interferon. Recent studies have shown that IL-28B polymorphisms of host are highly related to the treatment results. The relation of IL-28B polymorphisms and the response to interferon treatment in patients with chronic hepatitis C are reviewed in this paper.
作者 刘波 唐小平
出处 《国际流行病学传染病学杂志》 CAS 2012年第4期272-276,共5页 International Journal of Epidemiology and Infectious Disease
基金 广东省自然科学基金(S2011010005587)
关键词 多态性 单核苷酸 白细胞介素28B 丙型肝炎 干扰素 Polymorphisms, single nucleotide Interleukin-28B Hepatitis C Interferons
  • 相关文献

参考文献1

二级参考文献1

共引文献12

同被引文献30

  • 1徐道振,谢尧,陆志檬,骆抗先,贾继东,王宇明,赵桂珍,张树林,张大志.聚乙二醇干扰素α-2a与干扰素α-2a治疗慢性丙型肝炎疗效、安全性的评估[J].中华传染病杂志,2004,22(4):221-224. 被引量:37
  • 2Martins T, Narciso - Schiavon JL, Schiavon LL, et al. Epidemiolo- gy of hepatitis C virus infection[J]. Rev Assoc Med Bras, 2011, 57(1) : 107-112.
  • 3MeHutchison JG, Lawitz EJ, Shiffman ML, et cd. Peginterferon al- fa -2b or alfa -2a with ribavirin for treatment of hepatitis C infee- tion[J]. NEnglJMed, 2009, 361(6):580-593.
  • 4Bakr I, Rekaeewiez C, E1 Hosseiny M, et al. Higher clearance of hepatitis C virus infection in females compared with males [ J]. Gut, 2006, 55(8): 1183-1187.
  • 5Anand BS, Currie S, Dieperink E, et al. Alcohol use and treatmen of hepatitis C virus: results of a national multicenter study [J]. Gastroenterology, 2006, 130(6) : 1607 - 1616.
  • 6Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection [ J]. Nat Rev Immunol, 2005, 5 ( 3 ) : 215.
  • 7Dhillon R, Rossi S, Herrine SK. Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients [ J ]. Ther Clin Risk Manag, 2008, 4 (4) : 789 - 796.
  • 8Zeuzem S, Berg T, Moeller B, et al. Expert opinion on the treat- ment of patients with chronic hepatitis C[J]. J Viral Hepat, 2009, 16(2) : 75 -90.
  • 9Hadziyannis SJ, Sette H, Morgan TR. et al. Peginterferon - alpha 2a and ribavirin combination therapy in chronic hepatitis C - A ran- domized study of treatment duration and ribavirin dose[ J]. Ann Int Med, 2004, 140(5) : 346 -355.
  • 10McCarthy JJ, Li JH, Thompson A, et al. Replicatedassociation be- tween an IL28B gene variant and a sustained response to pegylated interferon and ribavirin [ J ]. Gastroenterology, 2010, 138 ( 7 ) : 2307 -2314.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部